Michael James Aiello - 03 Apr 2023 Form 3 Insider Report for BioXcel Therapeutics, Inc. (BTAI)

Role: 10%+ Owner
Signature: /s/ Michael James Aiello
Issuer symbol: BTAI
Transactions as of: 03 Apr 2023
Transactions value $: $0
Form type: 3
Filing time: 26 Apr 2023, 15:19:46 UTC
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	BTAI	Common Stock						8.55M	03 Apr 2023	By BioXcel LLC	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The Reporting Person in his capacity as trustee for two trusts may be deemed to share investment control over shares of common stock of the Issuer held by BioXcel LLC. The Reporting Person disclaims beneficial ownership of the securities reported herein except to the extent of his pecuniary interest therein, if any. This filing shall not be deemed an admission that the Reporting Person is the beneficial owner of any such shares of common stock for the purpose of Section 16 or for any other purpose.

Content

The Reporting Person in his capacity as trustee for two trusts may be deemed to share investment control over shares of common stock of the Issuer held by BioXcel LLC. The Reporting Person disclaims beneficial ownership of the securities reported herein except to the extent of his pecuniary interest therein, if any. This filing shall not be deemed an admission that the Reporting Person is the beneficial owner of any such shares of common stock for the purpose of Section 16 or for any other purpose.